Followers | 825 |
Posts | 119423 |
Boards Moderated | 16 |
Alias Born | 09/05/2002 |
Thursday, November 05, 2020 5:59:28 PM
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent ASMB News
- Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights • GlobeNewswire Inc. • 03/28/2024 08:05:00 PM
- Assembly Biosciences Announces Effective Date of Reverse Stock Split • GlobeNewswire Inc. • 02/08/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:05:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 04:01:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 09:05:09 PM
- Assembly Biosciences Provides Anticipated Development Milestones for 2024 • GlobeNewswire Inc. • 01/04/2024 01:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/21/2023 09:06:25 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/21/2023 09:01:49 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/11/2023 09:10:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2023 09:05:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:05:14 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:12:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 09:10:27 PM
- Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 11/10/2023 09:05:00 PM
- Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting® • GlobeNewswire Inc. • 11/10/2023 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:15:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:10:09 PM
- Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates • GlobeNewswire Inc. • 11/08/2023 09:05:00 PM
- Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer • GlobeNewswire Inc. • 11/08/2023 01:00:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/03/2023 08:05:03 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 10/31/2023 08:19:51 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 04:38:10 PM
- Assembly Biosciences Shares Soar Premarket on Gilead Pact • Dow Jones News • 10/17/2023 12:44:00 PM
- Gilead Taking Stake in Assembly Bio Under Antiviral Collaboration • Dow Jones News • 10/17/2023 11:51:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 11:10:04 AM
FEATURED Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • Apr 17, 2024 8:00 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM
Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • BLEG • Apr 16, 2024 8:30 AM